Futura Medical plc. (LON:FUM)‘s stock had its “corporate” rating reissued by investment analysts at N+1 Singer in a note issued to investors on Thursday.

Shares of Futura Medical plc. (LON:FUM) opened at 59.70 on Thursday. The firm has a 50-day moving average price of GBX 60.92 and a 200-day moving average price of GBX 37.70. Futura Medical plc. has a 12 month low of GBX 14.31 and a 12 month high of GBX 95.60. The company’s market capitalization is GBX 59.16 million.

COPYRIGHT VIOLATION WARNING: This piece was first published by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are accessing this piece on another site, it was stolen and republished in violation of US & international copyright law. The correct version of this piece can be accessed at https://www.thecerbatgem.com/2016/11/24/futura-medical-plc-fum-receives-corporate-rating-from-n1-singer.html.

Futura Medical plc. Company Profile

Futura Medical plc is a United Kingdom-based pharmaceutical company that develops products for consumer healthcare. The Company is engaged in the research and development of pharmaceutical drugs and medical devices and the commercial exploitation. It is also engaged in transdermal delivery and has developed a transdermal technology, DermaSys for the absorption of active molecules through the skin.

Receive News & Stock Ratings for Futura Medical plc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Futura Medical plc. and related stocks with our FREE daily email newsletter.